Form 8-K - Current report:
SEC Accession No. 0001213900-25-045641
Filing Date
2025-05-20
Accepted
2025-05-20 07:22:23
Documents
15
Period of Report
2025-05-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0242695-8k_incannex.htm   iXBRL 8-K 28233
2 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C ea024269501ex5-1_incannex.htm EX-5.1 12804
3 GRAPHIC ex5-1_001.jpg GRAPHIC 2691
4 GRAPHIC ex5-1_002.jpg GRAPHIC 1533
  Complete submission text file 0001213900-25-045641.txt   218050

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ixhl-20250520.xsd EX-101.SCH 3014
6 XBRL LABEL FILE ixhl-20250520_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE ixhl-20250520_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0242695-8k_incannex_htm.xml XML 3786
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25966155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)